Walter E Müller Selected Research

lavender oil

1/2021	Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties.
1/2018	Silexan in anxiety disorders: Clinical data and pharmacological background.
6/2014	Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
1/2013	Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.
12/2010	Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
9/2010	Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter E Müller Research Topics

Disease

30	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 06/2002
14	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 10/2003
8	Cognitive Dysfunction 01/2018 - 11/2005
7	Anxiety Disorders (Anxiety Disorder) 01/2021 - 09/2010
5	Dementia (Dementias) 10/2013 - 01/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2013 - 01/2008
4	Neoplasms (Cancer) 01/2010 - 02/2005
3	Inflammation (Inflammations) 01/2022 - 12/2010
3	Atrophy 01/2021 - 09/2003
3	Neuroblastoma 10/2013 - 06/2010
2	Body Weight (Weight, Body) 12/2007 - 06/2007
2	Hypercholesterolemia 04/2007 - 01/2005
2	Pheochromocytoma 05/2005 - 12/2003
1	COVID-19 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018
1	Schizophrenia (Dementia Praecox) 09/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 09/2016
1	Insulin Resistance 04/2015
1	Mental Disorders (Mental Disorder) 01/2014
1	Brain Injuries (Brain Injury) 10/2013
1	Chronic Disease (Chronic Diseases) 09/2011
1	Hypertension (High Blood Pressure) 09/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2011
1	Psychomotor Agitation (Akathisia) 12/2010
1	Syndrome (Syndromes) 07/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2010
1	Multiple Sclerosis 06/2010
1	Parkinson Disease (Parkinson's Disease) 06/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2010
1	Actinic Keratosis 01/2010
1	Nervous System Diseases (Neurological Disorders) 05/2009
1	Mood Disorders (Mood Disorder) 11/2006
1	Hypoglycemia (Reactive Hypoglycemia) 01/2006
1	Hypoxia (Hypoxemia) 01/2006
1	Frontotemporal Dementia (Semantic Dementia) 06/2005

Drug/Important Bio-Agent (IBA)

12	Amyloid (Amyloid Fibrils)IBA 01/2018 - 06/2002
11	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2002
11	Amyloid beta-PeptidesIBA 08/2012 - 03/2003
6	lavender oilIBA 01/2021 - 09/2010
5	CholesterolIBA 05/2014 - 03/2003
5	Ginkgo biloba extract (Rokan)IBA 08/2012 - 11/2005
4	Piracetam (Nootropil)IBA 01/2016 - 01/2006
4	Adenosine Triphosphate (ATP)IBA 04/2013 - 06/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2010 - 02/2005
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021 - 06/2014
3	Terpenes (Terpenoids)IBA 08/2010 - 10/2008
3	Mevalonic Acid (Mevalonate)IBA 06/2010 - 02/2005
3	CaspasesIBA 02/2007 - 10/2003
3	Flavin-Adenine Dinucleotide (FAD)IBA 12/2003 - 06/2002
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 09/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 09/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 08/2012
2	Volatile Oils (Essential Oils)IBA 01/2021 - 01/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2016 - 01/2016
2	Paroxetine (Paxil)FDA LinkGeneric 06/2014 - 07/2010
2	Pharmaceutical PreparationsIBA 10/2013 - 02/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013 - 08/2012
2	CurcuminIBA 04/2013 - 12/2010
2	CalciumIBA 08/2012 - 02/2011
2	Monomeric GTP-Binding ProteinsIBA 08/2010 - 08/2009
2	Simvastatin (Zocor)FDA LinkGeneric 06/2010 - 02/2007
2	Nootropic Agents (Nootropics)IBA 01/2010 - 01/2006
2	hyperforinIBA 05/2005 - 12/2003
1	Sigma-1 ReceptorIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	CytokinesIBA 01/2022
1	Fluvoxamine (Luvox)FDA LinkGeneric 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	SteamIBA 01/2021
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2016
1	Carbamazepine (Tegretol)FDA LinkGeneric 09/2016
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2016
1	Insulin (Novolin)FDA Link 04/2015
1	RotenoneIBA 06/2012
1	antimycinIBA 06/2012
1	TRPC6 Cation ChannelIBA 02/2011
1	Lorazepam (Ativan)FDA LinkGeneric 12/2010
1	PolyphenolsIBA 10/2010
1	AcidsIBA 10/2010
1	DolicholsIBA 08/2010
1	UbiquinoneIBA 08/2010
1	dolichol monophosphate (dolichyl phosphate)IBA 08/2010
1	Oxidoreductases (Dehydrogenase)IBA 06/2010
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 06/2010
1	TriterpenesIBA 01/2010
1	Therapeutic UsesIBA 01/2010
1	Keratin-10IBA 01/2010
1	LipidsIBA 05/2009
1	Peptides (Polypeptides)IBA 05/2009
1	Apolipoprotein E4IBA 12/2007
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 06/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2006
1	tau Proteins (tau Protein)IBA 07/2006
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 07/2006
1	PresenilinsIBA 03/2006

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2014 - 09/2011
1	Immunotherapy 01/2007